Company Information

FORTIS HEALTHCARE LTD.

NSE : FORTISBSE : 532843ISIN CODE : INE061F01013Industry : Hospital & Healthcare ServicesHouse : Fortis
BSE444.551.55 (+0.35 %)
PREV CLOSE ( ) 443.00
OPEN PRICE ( ) 443.30
BID PRICE (QTY) 444.50 (16)
OFFER PRICE (QTY) 445.20 (2)
VOLUME 12125
TODAY'S LOW / HIGH ( )442.30 449.45
52 WK LOW / HIGH ( )254.45 469.5
NSE445.650.8 (+0.18 %)
PREV CLOSE( ) 444.85
OPEN PRICE ( ) 442.10
BID PRICE (QTY) 445.50 (12)
OFFER PRICE (QTY) 445.70 (27)
VOLUME 204937
TODAY'S LOW / HIGH( ) 442.10 449.45
52 WK LOW / HIGH ( )254.75 469.7
ChairmanRavi Rajagopal
Managing DirectorAshutosh Raghuvanshi
Company SecretarySatyendra Chauhan
Non Executive DirectorTomo Nagahiro
Mehmet Ali Aydinlar
Lim Tsin Lin
Dilip Kadambi
Additional DirectorPrem Kumar Nair
Non Executive Independent DirectorIndrajit Banerjee
Suvalaxmi Chakraborty
Shailaja Chandra
Non Independent & Non Executive DirectorAshok Pandit
Incorporation Year : 28-02 1996

Registered Office :

Address : Fortis Hospital, Sector 62,Phase – Viii, Mohali,
Punjab-160062 .

Phone : 0172-5096001

Industry : Hospital & Healthcare Services

Listing : BSE,NSE,Luxembourg, MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.